Vanguard Group’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-43,829
Closed 4239
2015
Q4
$0 Sell
43,829
-600
-1% -$6.64K ﹤0.01% 4283
2015
Q3
$85K Sell
44,429
-56,622
-56% -$149K ﹤0.01% 4110
2015
Q2
$388K Buy
101,051
+11,913
+13% +$50.5K ﹤0.01% 3930
2015
Q1
$349K Buy
89,138
+13,678
+18% +$61.3K ﹤0.01% 3911
2014
Q4
$1.04M Buy
75,460
+8,736
+13% +$125K ﹤0.01% 3522
2014
Q3
$827K Buy
66,724
+7,888
+13% +$109K ﹤0.01% 3563
2014
Q2
$1.07M Buy
58,836
+10,448
+22% +$179K ﹤0.01% 3465
2014
Q1
$1.05M Buy
48,388
+12,428
+35% +$360K ﹤0.01% 3444
2013
Q4
$1.27M Buy
35,960
+4,745
+15% +$159K ﹤0.01% 3346
2013
Q3
$1.13M Buy
31,215
+23,671
+314% +$1.08M ﹤0.01% 3334
2013
Q2
$342K Buy
+7,544
New +$342K ﹤0.01% 3559

Other funds holding KBIO